CN100400113C - Preparation method of metal support surface micro blind hole drug-loaded layer - Google Patents

Preparation method of metal support surface micro blind hole drug-loaded layer Download PDF

Info

Publication number
CN100400113C
CN100400113C CNB2006101094228A CN200610109422A CN100400113C CN 100400113 C CN100400113 C CN 100400113C CN B2006101094228 A CNB2006101094228 A CN B2006101094228A CN 200610109422 A CN200610109422 A CN 200610109422A CN 100400113 C CN100400113 C CN 100400113C
Authority
CN
China
Prior art keywords
metal rack
support surface
blind hole
deionized water
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB2006101094228A
Other languages
Chinese (zh)
Other versions
CN1919353A (en
Inventor
董何彦
李昕跃
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIAONING YINYI BIOTECHNOLOGY CO., LTD.
Original Assignee
YINYI BIOLOGICAL MATERICAL RESEARCH AND DEVELOPMENT Co Ltd DALIAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YINYI BIOLOGICAL MATERICAL RESEARCH AND DEVELOPMENT Co Ltd DALIAN filed Critical YINYI BIOLOGICAL MATERICAL RESEARCH AND DEVELOPMENT Co Ltd DALIAN
Priority to CNB2006101094228A priority Critical patent/CN100400113C/en
Publication of CN1919353A publication Critical patent/CN1919353A/en
Application granted granted Critical
Publication of CN100400113C publication Critical patent/CN100400113C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

The invention discloses a preparing method of metal rack surface micro-blind hole drug-carrying layer, which comprises the following steps: a. heating NaOH solution at 100 deg.c to dispose metal rack surface, removing impurity and oxide film, cleaning through deionized water, drying, b. preparing 0.01-1.00mol/L etching liquid through analytical pure acid under normal temperature, marking the etching liquid, c. immersing the metal rack in the etching liquid under normal temperature for 8-20h, cleaning through deionized water, drying, d. allocating certain density of organic solution through organic solvent and metal rack carrier under normal temperature, e. placing metal rack with micro-blind hole on the surface in the organic solution under normal temperature, shocking through microwave for 15 min, drying.

Description

The manufacture method of metal support surface micro blind hole drug-loaded layer
Affiliated field
The present invention relates to the manufacture method of the manufacture method of micro blind hole drug-loaded layer, particularly metal support surface micro blind hole drug-loaded layer.The present invention is the innovative design on existing clinical medicine use metal rack basis, and we propose to make Microvia at metal support surface, make its carrier as medicine, thereby overcome the harmful effect that metal rack implants and produced.Metal rack is a biomaterial medical and that comply with the national standard requirements, as surgical implant rustless steel, cochrome, Nitinol etc.Can be applicable to make all netted supports of implant into body tube chamber inner cylinder, as angiocarpy bracket, cerebrovascular support, peripheral blood vessel support, splenic artery support, esophagus urethra rack etc.
Background technology
It is the narrow effective method for treatment of cardiovascular that the metal current support is got involved urethroptasty, and it is obvious that it has curative effect, and acute occlusion rate is low, advantages such as wide accommodation; But because the implantation of metal rack causes vascular endothelial injury and inflammatory reaction easily, make the new intima hyperplasia and form new scar tissue, cause restenosis; Relevant report and clinical practice confirm that the restenosis rate that metal rack is implanted in back a year can reach about 30%.For reducing the restenosis rate after metal rack is implanted, researchers have been developed medication coat slow release (or eluting) support, both drug stent through extremely hard and bitter effort; The drug stent coating method of having put on market mainly adopts macromolecular compound as carrier layer, and its advantage is that the positioning and slow release effect of medicine is reduced to below 10% restenosis; Implant back nine months following up a case by regular visits to and show that the restenosis rate that has can be lower than 4%; But new problem has occurred, and the macromolecular compound carrier layer makes in the blood vessel of human body has increased the metabolic material of a kind of new needs again.
Drug stent is to cover one deck macromolecule medicine carrying material on the backbone metal surface, because both elastic modelling quantity differ greatly, so between the two adhesion is difficult to the maintenance original state after support and twice retrospective deformation of the common experience of macromolecule drug-loaded layer; Again because Framework construction is that beam column and bridge muscle are spaced, so pressure is held and expanded north change process each point tension force must be inconsistent, thereby medicine-carrying polymer layer and metal rack interface are taken off and are occurred in varying degrees between the two, inflow blood flow in ground when being taken off fragment and not waiting causes the patient acute, subacute stent thrombosis and far-end of limb thrombosis to occur.
Summary of the invention
The present invention seeks to provides a kind of manufacture method of metal support surface micro blind hole drug-loaded layer at existing technological deficiency.Make Microvia at metal support surface, make its carrier, thereby overcome the shortcoming of ubi supra as medicine, again can target positioning and slow release medicine.
The present invention adopts electrochemical method, and metal support surface is handled.Utilize existing medical implant metal rack and corrosive liquid to interact; Make metal support surface form even relatively, a lot of Microvias of average pore size about 0.8-2.5 μ m.Increased the surface area of metal rack like this, when medicament-carried,, made that also medicine is relatively stable, be evenly dispersed in rack surface as the hiding-place of medicine; And in vivo in the blood vessel slowly, orientation discharges medicine, thereby plays due effect.
Correlational study of the present invention confirms, at a certain temperature, the medical stainless steel metal rack is immersed in the hydrochloric acid solution of concentration between 0.01-1.00mol/L, just can form even, a plurality of Microvias at rack surface behind the storing certain hour.First principles analysis according to redox reaction: when hydrochloric acid solution was 1.00mol/L, its standard electrode EMF was 0.0000V; Cr under acid condition + 2/ Cr, Cr + 3/ Cr + 2, Fe + 2/ Fe, Ni + 2The standard electrode EMF of/Ni is respectively :-0.91V ,-0.41V ,-0.44V ,-0.25V.Therefrom as can be seen, redox reaction, Fe, Cr then take place earlier in Cr metal and HCl + 2With the HCl effect; Last Ni again with the HCl effect.Its relevant reaction equation is as follows:
Cr+2HCl → CrCl 2(blueness)+H 2
4CrCl 2+ 4HCl+O 2→ 4CrCl 3(green)+2H 2O
Fe+2HCl → FeCl 2(green)+H 2
Ni+2HCl → NiCl 2(green)+H 2
According to above-mentioned analysis, metal rack such as surgical implant mainly contain transition active metal elements such as Fe, Cr, Ni with biomaterials such as rustless steel, cochrome, Nitinols, and the reaction expression with corrosive liquid is under certain condition:
M+2H +=M 2++H 2
M: be metallic atom; M 2+For having the metal ion of two positive charges; The metal ion that dissociates is out removed by cleaning.
The manufacture method of metal support surface micro blind hole drug-loaded layer may further comprise the steps:
A, with the heating about 100 ℃ NaOH solution metal support surface is handled, remove existing impurity and oxide-film, use the deionized water cleaning, drying then;
B, at normal temperatures accurately prepares the 0.01-1.00mol/L corrosive liquid with analytically pure acid, and corrosive liquid is demarcated;
C, at normal temperatures with the above-mentioned metal rack of having handled, is immersed in about 8h-20h in the corrosive liquid of having demarcated, takes out back washed with de-ionized water, drying;
D, at normal temperatures with the medicine that volatile organic solvent and metal rack carried, prepares certain density organic solution;
E, at normal temperatures forms the metal rack of Microvia with the surface, put into be dissolved with medicament-carried organic solution, through microwave concussion 15min, take out after drying.
The invention is characterized in the key property that does not change metal rack, used corrosive liquid is non-oxidizing HCl, H 2SO 4Deng solution, and strict control concentration, the temperature of reaction and the time of effect, make metal support surface micro blind hole size, how much controlled, both can reach the purpose of a certain amount of medicine of carrying.
At the Microvia of metal support surface made, its average pore size is about 0.8-2.5 μ m; At antitumor drug such as paclitaxel, the rapamycin etc. of clinical use, its bulk of molecule is between the hundreds of nanometer; So the micropore of metal support surface can load a certain amount of medicine fully; The existence of metal support surface micro blind hole has correspondingly increased the surface area and the medicine carrying space of metal rack, makes the relative firm attachment of medicine in metal support surface; Simultaneously because the distribution of Microvia is again more uniform, so medicine also can scatter and play the effect of target positioning and slow release medicine very equably.
The specific embodiment
Example 1, with metal rack n piece, put in the NaOH solution of 100ml 2.00mol/L, be heated to 100 ℃, take out behind the 30min with deionized water clean, dry.Be immersed in then in the hydrochloric acid solution of 50ml 1.00mol/L, place 8h, clean, dry after taking out with deionized water; Put it at last be dissolved with in the medicament-carried organic solution, through microwave concussion 15min, take out after drying.
Example 2, with metal rack n piece, put in the NaOH solution of 100ml 2.00mol/L, be heated to 100 ℃, take out behind the 30min with deionized water clean, dry.Be immersed in then in the hydrochloric acid solution of 50ml 0.50mol/L, place 16h, clean, dry after taking out with deionized water; Put it at last be dissolved with in the medicament-carried organic solution, through microwave concussion 15min, take out after drying.
Example 3, with n piece of metal rack, handle the back through aqueous slkali and interact with corrosive liquid, make metal support surface form even relatively, a lot of Microvias of average pore size about 0.8-2.5 μ m; Put it into the CHCl that is dissolved with paclitaxel or rapamycin medicine then 3Or other volatile organic solvent, concentration is in the solution of 5mg/ml, through microwave concussion 15min, takes out after drying.

Claims (4)

1. the manufacture method of metal support surface micro blind hole drug-loaded layer may further comprise the steps:
A, metal support surface is handled, removed existing impurity and oxide-film, take out behind the 30min, use the deionized water cleaning, drying with the 100ml, the 2.00mol/L NaOH solution that are heated to 100 ℃;
B, at normal temperatures accurately prepares the 0.01-1.00mol/L corrosive liquid with analytically pure acid, and corrosive liquid is demarcated;
C, at normal temperatures with the above-mentioned metal rack of having handled, is immersed in 8h-20h in the corrosive liquid of having demarcated concentration, takes out the back and uses washed with de-ionized water, and drying obtains even, a plurality of Microvias and the average pore size metal rack at 0.8-2.5 μ m;
D, at normal temperatures, with the medicine that volatile organic solvent and metal rack carried, compound concentration is the organic solution of 5mg/ml;
E, at normal temperatures forms the metal rack of Microvia with the surface, put into be dissolved with medicament-carried organic solution, through microwave concussion 15min, take out after drying.
2. according to the manufacture method of the described metal support surface micro blind hole drug-loaded layer of claim 1, may further comprise the steps:
A, metal rack is put in the 100ml 2.00mol/L NaOH solution that is heated to 100 ℃, is taken out behind the 30min, with deionized water clean, dry;
B, cleaning and dried metal rack are immersed in the corrosive liquid of 50ml, 0.50mol/L, place 16h, and be clean, dry with deionized water after taking out.
3. according to the manufacture method of the described metal support surface micro blind hole drug-loaded layer of claim 1, may further comprise the steps:
A, metal rack is put in the 100ml 2.00mol/L NaOH solution that is heated to 100 ℃, is taken out behind the 30min, with deionized water clean, dry;
B, cleaning and dried metal rack are immersed in the corrosive liquid of 50ml, 1.00mol/L, place 8h, and be clean, dry with deionized water after taking out; Carrying out medicine then loads.
4. according to the manufacture method of the described metal support surface micro blind hole drug-loaded layer of claim 1, may further comprise the steps:
A, at normal temperatures is dissolved in CHCl with paclitaxel or rapamycin medicine 3, concentration is in the solution of 5mg/ml;
B, the surface is formed the metal rack of Microvia, put into above-mentioned solution,, take out after drying through microwave concussion 15min.
CNB2006101094228A 2006-08-14 2006-08-14 Preparation method of metal support surface micro blind hole drug-loaded layer Active CN100400113C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101094228A CN100400113C (en) 2006-08-14 2006-08-14 Preparation method of metal support surface micro blind hole drug-loaded layer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101094228A CN100400113C (en) 2006-08-14 2006-08-14 Preparation method of metal support surface micro blind hole drug-loaded layer

Publications (2)

Publication Number Publication Date
CN1919353A CN1919353A (en) 2007-02-28
CN100400113C true CN100400113C (en) 2008-07-09

Family

ID=37777289

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101094228A Active CN100400113C (en) 2006-08-14 2006-08-14 Preparation method of metal support surface micro blind hole drug-loaded layer

Country Status (1)

Country Link
CN (1) CN100400113C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199873B (en) * 2006-12-14 2013-06-19 乐普(北京)医疗器械股份有限公司 Medicament elution instrument nanometer class colon washer machineole drug releasing structure and preparing method thereof
CN101313873B (en) * 2007-05-31 2011-03-23 乐普(北京)医疗器械股份有限公司 Biology polypeptide medicament blood vessel bracket and preparation method thereof
CN101883592A (en) * 2007-10-10 2010-11-10 Miv治疗有限公司 Calcium phosphate coated stents comprising cobalt chromium alloy
WO2010048757A1 (en) * 2008-10-31 2010-05-06 Dong Heyan Method for preparation of rack with micro-blind holes on the surface carrying gene material
CN108404228A (en) * 2018-03-14 2018-08-17 广东工业大学 A kind of preparation method of stainless steel nano drug-carrying holder and slow-releasing agent
CN111249601A (en) * 2018-11-30 2020-06-09 上海微创医疗器械(集团)有限公司 Porous balloon and preparation method thereof
CN115317675B (en) * 2022-08-23 2024-02-27 苏州中天医疗器械科技有限公司 Drug eluting stent and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050055080A1 (en) * 2003-09-05 2005-03-10 Naim Istephanous Modulated stents and methods of making the stents
CN1725988A (en) * 2002-11-13 2006-01-25 斯特根有限公司 Medical apparatus and manufacture method thereof with porous layer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1725988A (en) * 2002-11-13 2006-01-25 斯特根有限公司 Medical apparatus and manufacture method thereof with porous layer
US20050055080A1 (en) * 2003-09-05 2005-03-10 Naim Istephanous Modulated stents and methods of making the stents

Also Published As

Publication number Publication date
CN1919353A (en) 2007-02-28

Similar Documents

Publication Publication Date Title
CN100400113C (en) Preparation method of metal support surface micro blind hole drug-loaded layer
US7208172B2 (en) Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices
CN101199873B (en) Medicament elution instrument nanometer class colon washer machineole drug releasing structure and preparing method thereof
KR100826574B1 (en) Medical devices having porous layers and methods for making same
CN101161299B (en) Medicament release structure carrying apertured and polyalcohol as well as its preparing method
CN102309368B (en) Body lumen drug-carrying bracket and preparation method thereof
CN104857570A (en) Degradable zinc-based alloy bracket and preparation method thereof
EP2380528A1 (en) Medicament eluting apparatus with micro-hole structure capable of storing and releasing multiple medicines and preparation method
CN101327343A (en) Compound medicament intravascular stent and preparation method thereof
JP2012519545A (en) Artificial organ
CN106310372B (en) Degradable magnesium-based intrabony implant drug-loaded polymer/calcium-phosphorus composite coating and preparation
CN105833358B (en) Intracranial drug eluting stent system and preparation method thereof
JP2021506467A (en) Charged implantable medical device and how to prepare it
Saraf et al. Fundamentals of bare-metal stents
JP2014530058A (en) Intervention medical device and manufacturing method thereof
US20160000967A1 (en) Medical device with a biocompatible coating
Katona et al. Chemical etching of nitinol stents
CN101054702B (en) Method for manufacturing dimple on blood vessel metal support
CN108714252A (en) The preparation method of the magnesium alloy fixing screws of internal controlled degradation
CN102309369B (en) Metal support and manufacturing method thereof
JP6089053B2 (en) Biodegradable metal surface modified stent with anticorrosive ability
CN104983492A (en) Spraying liner structure and method for assisting in spraying medicine on absorbable stent
CN204909753U (en) Assist and to absorb spraying lining structure that support carries out medicine spraying
CN105797207A (en) Drug release carrier on metal substrate and preparation method thereof
CN1694770A (en) Metallic structures incorporating bioactive materials and methods for creating the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Liaoning Biomedical Materials R&D Center Co., Ltd.

Assignor: Dong Heyan|Yinyi Biological Materical Research and Development Co., Ltd., Dalian

Contract fulfillment period: 2008.12.1 to 2016.11.30 contract change

Contract record no.: 2008210000087

Denomination of invention: Preparation method of metal support surface micro blind hole drug-loaded layer

Granted publication date: 20080709

License type: Exclusive license

Record date: 2008.12.9

LIC Patent licence contract for exploitation submitted for record

Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.12.1 TO 2016.11.30; CHANGE OF CONTRACT

Name of requester: LIAONING BIOLOGY MEDICINE MATERIALS RESEARCH CENTE

Effective date: 20081209

ASS Succession or assignment of patent right

Owner name: LIAONING BIOLOGY MEDICINE MATERIALS RESEARCH CENTE

Free format text: FORMER OWNER: DONG HEYAN

Effective date: 20090925

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20090925

Address after: Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road 811. Zip code: 116100

Patentee after: Liaoning Biomedical Materials R&D Center Co., Ltd.

Address before: 150-5, No. 54, Shahekou Road, Dalian District, Liaoning, 116021

Co-patentee before: Yinyi Biological Materical Research and Development Co., Ltd., Dalian

Patentee before: Dong ho Yan

ASS Succession or assignment of patent right

Owner name: LIAONING BIOLOGY MEDICINE MATERIALS RESEARCH CENTE

Free format text: FORMER OWNER: DONG HEYAN

Effective date: 20100122

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20100122

Address after: Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road 811. Zip code: 116100

Patentee after: Liaoning Biomedical Materials R&D Center Co., Ltd.

Address before: 150-5, No. 54, Shahekou Road, Dalian District, Liaoning, 116021

Co-patentee before: Yinyi Biological Materical Research and Development Co., Ltd., Dalian

Patentee before: Dong ho Yan

C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road No. 8-11 116100

Patentee after: LIAONING YINYI BIOTECHNOLOGY CO., LTD.

Address before: Guangming Street Jinzhou District of Dalian City, Liaoning Province, Han Road No. 8-11 116100

Patentee before: Liaoning Biomedical Materials R&D Center Co., Ltd.